Dr. Reddy's Laboratories
RDY
#1699
Rank
โ‚น1.066 T
Marketcap
โ‚น1,275
Share price
0.35%
Change (1 day)
4.68%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): โ‚น342.14 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is โ‚น355.53 Billion. In 2024 the company made a revenue of โ‚น311.30 Billion an increase over the revenue in the year 2023 that were of โ‚น271.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น342.14 B9.91%
2024 โ‚น311.30 B14.74%
2023 โ‚น271.30 B14.34%
2022 โ‚น237.27 B14.46%
2021 โ‚น207.30 B11%
2020 โ‚น186.75 B9.57%
2019 โ‚น170.44 B14.37%
2018 โ‚น149.03 B4.79%
2017 โ‚น142.22 B-0.43%
2016 โ‚น142.82 B-8.35%
2015 โ‚น155.85 B8.01%
2014 โ‚น144.29 B10.35%
2013 โ‚น130.76 B27.39%
2012 โ‚น102.64 B13.64%
2011 โ‚น90.32 B27.32%
2010 โ‚น70.94 B-3.75%
2009 โ‚น73.70 B17.35%
2008 โ‚น62.80 B20.57%
2007 โ‚น52.09 B-7.83%
2006 โ‚น56.51 B148.17%
2005 โ‚น22.77 B15.8%
2004 โ‚น19.66 B0.44%
2003 โ‚น19.58 B10.24%
2002 โ‚น17.76 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.640 T 1,486.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T 323.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น3.804 T 970.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚น5.064 T 1,324.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น4.269 T 1,100.85%๐Ÿ‡ซ๐Ÿ‡ท France